Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Topical finasteride is an effective and safer treatment for male hair loss.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

More symptoms during initial COVID infection increase the risk of long-term effects.

Certain genes related to sulfur metabolism are more active during the growth phase of Cashmere goat wool, and melatonin might help this process.

The combination treatment showed a higher response rate but no significant survival benefits.

Fat grafting is safe and effective in both active and stable phases of localized scleroderma.

Vitamin A affects the resting phase of hair growth, with both low and high levels increasing the number of hair follicles in this phase.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Autoimmune reactions may cause both alopecia areata and HAM.

Exosome treatment from stem cells improved hair regrowth and reduced scalp issues in a woman with lichen planopilaris.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

Some patients experience temporary hair loss after ulcerative colitis surgery, likely due to illness rather than the surgery itself, and it usually grows back within six months.

Chronic critical illness often leads to long ICU stays and ongoing health issues after surviving the initial critical phase.

VEGF and microvessel density are closely linked and peak during specific hair growth phases in cashmere goats.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.